182 related articles for article (PubMed ID: 32945407)
21. Different Expression Patterns of Toll-Like Receptor mRNAs in Blood Mononuclear Cells of IgA Nephropathy and IgA Vasculitis with Nephritis.
Saito A; Komatsuda A; Kaga H; Sato R; Togashi M; Okuyama S; Wakui H; Takahashi N
Tohoku J Exp Med; 2016 Nov; 240(3):199-208. PubMed ID: 27818460
[TBL] [Abstract][Full Text] [Related]
22. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
23. Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection.
Zheng N; Fan J; Wang B; Wang D; Feng P; Yang Q; Yu X
Mol Med Rep; 2017 Apr; 15(4):1925-1935. PubMed ID: 28260100
[TBL] [Abstract][Full Text] [Related]
24. Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients.
Guo N; Zhou Q; Huang X; Yu J; Han Q; Nong B; Xiong Y; Liang P; Li J; Feng M; Lv J; Yang Q
BMC Immunol; 2020 Mar; 21(1):16. PubMed ID: 32234013
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of microRNA‑140‑3p mediates dachshund family transcription factor 1 expression in immunoglobulin A nephropathy through cell cycle‑dependent mechanisms.
Zhou X; Lu Y; Guo P; Zhou C
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313942
[TBL] [Abstract][Full Text] [Related]
26. The upregulation of miR-98-5p affects the glycosylation of IgA1 through cytokines in IgA nephropathy.
Liu D; Xia M; Liu Y; Tan X; He L; Liu Y; Chen G; Liu H
Int Immunopharmacol; 2020 Feb; 82():106362. PubMed ID: 32126510
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of IL-6 in IgA nephropathy patients are induced by an epigenetically driven mechanism modulated by viral and bacterial RNA.
Sallustio F; Picerno A; Cimmarusti MT; Montenegro F; Curci C; De Palma G; Sivo C; Annese F; Fontò G; Stasi A; Pesce F; Tafuri S; Di Leo V; Gesualdo L
Eur J Intern Med; 2023 Dec; 118():108-117. PubMed ID: 37550110
[TBL] [Abstract][Full Text] [Related]
28. TLR9 and BAFF: their expression in patients with IgA nephropathy.
Li W; Peng X; Liu Y; Liu H; Liu F; He L; Liu Y; Zhang F; Guo C; Chen G; Zhang L; Dong Z; Peng Y
Mol Med Rep; 2014 Sep; 10(3):1469-74. PubMed ID: 24993857
[TBL] [Abstract][Full Text] [Related]
29. Integrated Analysis and Identification of mRNAs, Circular RNAs, and Long Noncoding RNAs in Immunoglobulin A Nephropathy.
Lin H; Tan Q; Tang D; Chen J; Xue W; Zhang Y; Xu H; Dai Y
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):520-530. PubMed ID: 38725202
[TBL] [Abstract][Full Text] [Related]
30. Expression profile of Fc receptor-like molecules in patients with IgA nephropathy.
Zhong Z; Shi D; Xiao M; Fu D; Feng S; Kong Q; Li J; Li Z
Hum Immunol; 2021 Mar; 82(3):186-192. PubMed ID: 33597097
[TBL] [Abstract][Full Text] [Related]
31. Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.
Zhai Y; Qi Y; Long X; Dou Y; Liu D; Cheng G; Xiao J; Liu Z; Zhao Z
J Cell Mol Med; 2019 Nov; 23(11):7299-7309. PubMed ID: 31557418
[TBL] [Abstract][Full Text] [Related]
32. The Association of rs1047763 and rs1008898 of C1GALT1 with IgA Nephropathy Risk: A Global Meta-Analysis.
Nie R; Cheng G; Zhang J; Dong Y; Wang C; Liu J; Qin X
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):95-103. PubMed ID: 28636500
[TBL] [Abstract][Full Text] [Related]
33. Deciphering prognostic value of CD22 and its contribution to suppression of proinflammatory cytokines production in patients with IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Cao H; Jia J; Yan T
Immunol Lett; 2023 Mar; 255():40-46. PubMed ID: 36848961
[TBL] [Abstract][Full Text] [Related]
34. Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients.
Cox SN; Serino G; Sallustio F; Blasi A; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2015 Jul; 30(7):1122-232. PubMed ID: 25770168
[TBL] [Abstract][Full Text] [Related]
35. miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14.
Guo Y; Liao Y
Int Immunopharmacol; 2017 Nov; 52():150-155. PubMed ID: 28910745
[TBL] [Abstract][Full Text] [Related]
36. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy.
Pirulli D; Crovella S; Ulivi S; Zadro C; Bertok S; Rendine S; Scolari F; Foramitti M; Ravani P; Roccatello D; Savoldi S; Cerullo G; Lanzilotta SG; Bisceglia L; Zelante L; Floege J; Alexopoulos E; Kirmizis D; Ghiggeri GM; Frascà G; Schena FP; Amoroso A;
J Nephrol; 2009; 22(1):152-9. PubMed ID: 19229831
[TBL] [Abstract][Full Text] [Related]
37. Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.
Chen X; Liu H; Peng Y; He L; Zhang Y; Xie Y; Peng X; Liu C; Liu F
Cell Immunol; 2014; 289(1-2):70-5. PubMed ID: 24732061
[TBL] [Abstract][Full Text] [Related]
38. Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy.
Cox SN; Sallustio F; Serino G; Loverre A; Pesce F; Gigante M; Zaza G; Stifanelli PF; Ancona N; Schena FP
Kidney Int; 2012 Sep; 82(5):548-60. PubMed ID: 22572859
[TBL] [Abstract][Full Text] [Related]
39. Association between C1GALT1 variants and genetic susceptibility to IgA nephropathy in Uygur.
Li WL; Lu C
Genet Mol Res; 2015 May; 14(2):5327-33. PubMed ID: 26125729
[TBL] [Abstract][Full Text] [Related]
40. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
